rs3746248
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002361.4(MAG):c.462G>A(p.Glu154Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 1,605,214 control chromosomes in the GnomAD database, including 53,956 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 12254 hom., cov: 26)
Exomes 𝑓: 0.22 ( 41702 hom. )
Consequence
MAG
NM_002361.4 synonymous
NM_002361.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0520
Genes affected
MAG (HGNC:6783): (myelin associated glycoprotein) The protein encoded by this gene is a type I membrane protein and member of the immunoglobulin superfamily. It is thought to be involved in the process of myelination. It is a lectin that binds to sialylated glycoconjugates and mediates certain myelin-neuron cell-cell interactions. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-35299600-G-A is Benign according to our data. Variant chr19-35299600-G-A is described in ClinVar as [Benign]. Clinvar id is 1168416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.052 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.668 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAG | NM_002361.4 | c.462G>A | p.Glu154Glu | synonymous_variant | 5/11 | ENST00000392213.8 | NP_002352.1 | |
MAG | NM_001199216.2 | c.387G>A | p.Glu129Glu | synonymous_variant | 5/11 | NP_001186145.1 | ||
MAG | NM_080600.3 | c.462G>A | p.Glu154Glu | synonymous_variant | 5/12 | NP_542167.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAG | ENST00000392213.8 | c.462G>A | p.Glu154Glu | synonymous_variant | 5/11 | 1 | NM_002361.4 | ENSP00000376048.2 |
Frequencies
GnomAD3 genomes AF: 0.346 AC: 52391AN: 151296Hom.: 12231 Cov.: 26
GnomAD3 genomes
AF:
AC:
52391
AN:
151296
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.258 AC: 62980AN: 244250Hom.: 9863 AF XY: 0.250 AC XY: 33194AN XY: 132608
GnomAD3 exomes
AF:
AC:
62980
AN:
244250
Hom.:
AF XY:
AC XY:
33194
AN XY:
132608
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.225 AC: 326661AN: 1453800Hom.: 41702 Cov.: 35 AF XY: 0.224 AC XY: 161564AN XY: 721642
GnomAD4 exome
AF:
AC:
326661
AN:
1453800
Hom.:
Cov.:
35
AF XY:
AC XY:
161564
AN XY:
721642
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.347 AC: 52467AN: 151414Hom.: 12254 Cov.: 26 AF XY: 0.344 AC XY: 25421AN XY: 73954
GnomAD4 genome
AF:
AC:
52467
AN:
151414
Hom.:
Cov.:
26
AF XY:
AC XY:
25421
AN XY:
73954
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1246
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 75 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 30, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at